Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Sulforaphane glucosinolate (SGS), found in cruciferous vegetables such as broccoli, has garnered scientific interest for its potential anti-inflammatory and antioxidative properties, which may be relevant in the context of Rheumatoid Arthritis (RA). Preclinical studies indicate that sulforaphane, the active form released from SGS, can inhibit the activation of nuclear factor kappa B (NF-κB) and reduce the production of pro-inflammatory cytokines such as TNF-α and IL-1β, both of which play significant roles in RA pathogenesis. Animal models of arthritis have shown that sulforaphane can decrease joint inflammation and cartilage destruction. However, direct clinical evidence in humans with RA is limited. Some small clinical studies and pilot trials suggest that consumption of broccoli or sulforaphane-rich extracts may reduce markers of inflammation, but these effects have not been robustly demonstrated in large, well-controlled clinical trials specifically targeting RA. The use of SGS for RA is therefore supported by mechanistic rationale and promising animal data, but lacks substantial evidence from human studies. Consequently, while the scientific interest is strong and early data is encouraging, the overall quality and quantity of evidence justifies only a modest rating at this time.

More about sulforaphane glucosinolate
More about Rheumatoid Arthritis

Other ingredients used for Rheumatoid Arthritis

Other health conditions supported by sulforaphane glucosinolate

Products containing sulforaphane glucosinolate

Thorne Crucera-SGS